Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK building up R&D, manufacturing and goodwill in Africa
Fierce Pharma
Monday, March 31, 2014 - 4:43pm
tags:
R&D, GSK, Africa
Biogen hemophilia nod puts Baxter's to-be-spun-off biopharma unit on notice
Fierce Pharma
Monday, March 31, 2014 - 4:41pm
tags:
hemophilia B, Biogen Idec, Baxter International, Alprolix
Durata's anti-infective drug shows efficacy, safety -FDA panel
Yahoo/Zacks.com
Monday, March 31, 2014 - 4:39pm
tags:
Durata, FDA, advisory panels, dalbavancin
Does Arena Pharmaceuticals Have An Anti-Smoking Opportunity?
Motley Fool
Monday, March 31, 2014 - 4:35pm
tags:
Arena Pharmaceuticals, smoking cessation, Belviq
Shares of MannKind Plummet Prior to Drug Advisory Meeting
Yahoo/Benzinga
Monday, March 31, 2014 - 4:23pm
tags:
FDA, MannKind, Afrezza
Glaxo scraps the ovarian cancer app for Votrient
Fierce Biotech
Monday, March 31, 2014 - 11:51am
tags:
Europe, GSK, ovarian cancer, Votrient
Sanofi aims for outcomes with brand-new Chief Patient Officer
Fierce Pharma Marketing
Monday, March 31, 2014 - 11:51am
tags:
Sanofi, patient outcomes
FDA panel says Cubist anti-infective shows efficacy, safety
Yahoo/Reuters
Monday, March 31, 2014 - 11:49am
tags:
FDA, Cubist Pharmaceuticals, antibiotics, tedizolid
Glaxo's Utter Stinkbomb Of A Drug
Forbes
Monday, March 31, 2014 - 11:44am
tags:
GSK, darapladib
Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx
Yahoo/Benzinga
Monday, March 31, 2014 - 11:25am
tags:
Isis Pharmaceuticals, ISIS-APOCIIIRx, hypertriglyceridemia
Supreme Court to decide patent dispute over multiple sclerosis treatment
Yahoo/AP
Monday, March 31, 2014 - 11:00am
tags:
Supreme Court, MS, multiple sclerosis, Copaxone, Teva Pharmaceuticals, Sandoz, Mylan, Momenta
Future Of Marijuana Companies: GW Pharma's Strong Fundamentals Leading The Charge
Seeking Alpha
Monday, March 31, 2014 - 10:21am
tags:
Medical Marijuana, GW Pharma, Sativex
Alliqua Appoints 20 Direct Sales Representatives to Strengthen Brand Awareness and Drive Greater Market Penetration in the U.S.
Yahoo
Monday, March 31, 2014 - 10:19am
tags:
Alliqua, hirings, wound care
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
TheStreet.com
Monday, March 31, 2014 - 10:18am
tags:
Amgen, cholesterol, evolocumab
Novartis halts Phase III study of heart failure drug LCZ696 early on positive results
First Word Pharma
Monday, March 31, 2014 - 9:59am
tags:
LCZ696, Novartis, heart failure
Mannkind: The Best Afrezza FDA Panel Preview Ever
TheStreet.com
Monday, March 31, 2014 - 9:53am
tags:
FDA, Afrezza, advisory panels, diabetes, MannKind
Oxygen Biotherapeutics Inc. Provides an Update on Communication with the FDA Regarding Oxycyte Development Program; Hold Has Been Lifted
Yahoo/Benzinga
Monday, March 31, 2014 - 9:44am
tags:
FDA, Oxygen Biotherapeutics, Oxycyte
Prana Alzheimer's Study Fails
TheStreet.com
Monday, March 31, 2014 - 9:38am
tags:
Prana Biotechnology, Alzheimer's disease, PBT2
$4B deal: J&J sells lab testing unit to Carlyle
USA Today
Monday, March 31, 2014 - 9:36am
tags:
JNJ, M&A, Carlyle, diagnostics, Ortho-Clinical Diagnostics
GSK CEO says success of heart drug 'an open question'
Yahoo/Reuters
Monday, March 31, 2014 - 9:35am
tags:
GSK, Pharma CEOs, darapladib, Andrew Witty, heart attack

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.